The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

AstraZeneca Oncology iScience Retains TCG For Chief Scientific Leadership Position

July 16, 2015
The Chase Group has been retained to conduct a search to identify an industry leader to serve as the Chief Scientific Leader for their iSciences immune-oncology small molecule early development team. The Chief Scientist will be responsible for leading the strategy for AstraZeneca’s immune-oncology development efforts, along with being the interface with the biologics immune-oncology efforts at MedImmune. For more information, please contact


Share This News Post

© Copyright 1993-2022 The Chase Group; All Rights Reserved.